Viewing Study NCT00281632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-05-05 @ 11:17 AM
Study NCT ID: NCT00281632
Status: COMPLETED
Last Update Posted: 2018-09-17
First Post: 2006-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peritoneal Cancer View
None Ovarian Cancer View
None Neoplasms, Ovarian View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pazopanib View
None Fallopian tube cancer View
None Ovarian epithelial cancer View
None Peritoneal cancer View